ArticleAging cell2026
Associations Between 40-Year Trajectories of BMI and Proteomic and Epigenetic Aging Clocks: Deciphering Nonlinearity and Interactions.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations Between 40-Year Trajectories of BMI and Proteomic and Epigenetic Aging Clocks: Deciphering Nonlinearity and Interactions.Aging cell · 2026Article
- Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The potential of proteomic aging clocks for obesity research, and the extent of nonlinearity in longitudinal associations between body weight and biological aging, remain underexplored. We investigated how BMI at ages 18 and ~60, as well as changes in BMI from age 18 to ~60, relate to downstream epigenetic and proteomic aging. We also examined nonlinearity and interactions in these associations. Analyses were conducted in 401 Finnish twins with up to nine self-reported or measured BMI values collected over 40 years. Olink proteomic and Illumina DNA methylation data were generated from blood drawn at the last BMI measurement. From these data, we derived four proteomic and five epigenetic age estimates and modeled BMI change over time using mixed-effects models. Generalized additive models were then applied to examine (1) nonlinear associations between BMI trajectories and biological aging, adjusting for chronological age, and (2) interactions of baseline BMI with BMI change and BMI at ~60 years. BMI at 18 and ~60 years old and changes in BMI were associated with increased biological aging for most aging estimates. We found statistical evidence of nonlinearity for about one-third of the significant associations, mostly observed for proteomic clocks. We further identified suggestive evidence for interactions between BMI at 18 years and BMI at ~60 years in explaining variability in two proteomic clocks (p = 0.07; p = 0.09). In conclusion, our study illustrates the potential of proteomic clocks in obesity research and highlights that assuming linearity in associations between BMI trajectories and biological aging is a critical oversight.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.